Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors
- 1 December 2002
- journal article
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 13 (8) , 633-638
- https://doi.org/10.1097/00008877-200212000-00004
Abstract
The administration of nafadotride, given at doses known to block the D3 dopamine receptors (0.75, 1.5, 3 mg/kg i.p.) increased locomotor activity both in naive and habituated rats and counteracted the hypothermia but not the hypomotility induced by a low dose of the putative D3 dopamine agonist (+/-)-7-hydroxy-2-(di-N-propylamino)-tetralin (7-OH-DPAT; 0.04 mg/kg). Nafadotride did not antagonize either the motor effects induced by different doses of the D2 agonist quinpirole (0.05 and 0.3 mg/kg) or the hypermotility induced by 7-OH-DPAT given at a dose (0.32 mg/kg) stimulating D2 dopamine receptors. The same nafadotride doses potentiated the grooming behavior induced by the D1 dopamine agonist SKF 38393 (10 mg/kg i.p.) as well as the stereotyped response to the D1/D2 agonist apomorphine (0.5 mg/kg s.c.). Stereotyped behavior was also observed in rats concomitantly treated with nafadotride and the D2 agonist quinpirole. As the activation of D1 dopamine receptors plays an important role in the occurrence of stereotypies, the results suggest that the blockade of D3 receptors by nafadotride could have favored D1/D2 dopamine receptor-mediated behaviors by potentiating D1 receptor function.Keywords
This publication has 26 references indexed in Scilit:
- Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonistsNeuropharmacology, 1999
- Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type miceNeuropharmacology, 1999
- A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.Proceedings of the National Academy of Sciences, 1996
- Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated ratEuropean Journal of Pharmacology, 1994
- Opposing Roles for Dopamine D2 and D3 Receptors on Neurotensin mRNA Expression in Nucleus AccumbensEuropean Journal of Neuroscience, 1994
- Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other “D-2-like” agonistsNeuropharmacology, 1993
- Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNABrain Research, 1991
- Synergistic blockade of some dopamine-mediated behaviours by (?)-sulpiride and SCH 23390 in the ratPsychopharmacology, 1989
- Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in ratsEuropean Journal of Pharmacology, 1987
- Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviorsEuropean Journal of Pharmacology, 1986